Skip to main content
. Author manuscript; available in PMC: 2011 Feb 1.
Published in final edited form as: Cardiovasc Toxicol. 2007;7(2):86–91. doi: 10.1007/s12012-007-0012-6

Fig. 3.

Fig. 3

Membrane-associated iPLA2 activity in hearts from control and DOX-treated rats. Animals were given bolus injection of either saline or doxorubicin (4 mg/kg weight) and myocardial enzyme activity was assessed 4 h later [1]